Showing results (11-20 of 144) with videos related to

Sort By:
Pageof 15
Plos One|October 6, 2022
Prognostic value of FOXP3+ regulatory T cells for patients with locally advanced oropharyngeal squamous cell carcinomaJoon Young Hur, Bo Mi Ku, Sehhoon Park, et al.
Chemotherapy|August 5, 2021
Treatment and Outcomes of Metastatic Pancreatic Cancer in Elderly PatientsHyun Ae Jung, Bo Ram Han, Ho Young Kim, et al.
Biology|October 10, 2020
Treatment and Outcomes of Metastatic Non-Small-Cell Lung Cancer Harboring Uncommon <i>EGFR</i> Mutations: Are They Different from Those with Common <i>EGFR</i> Mutations?Hyun Ae Jung, Sehhoon Park, Jong-Mu Sun, et al.
Cancer Research and Treatment|July 14, 2023
First-Line Alectinib vs. Brigatinib in Advanced Non-Small Cell Lung Cancer with ALK Rearrangement: Real-World DataYoungkyung Jeon, Sehhoon Park, Hyun Ae Jung, et al.
Cancer Research and Treatment|October 13, 2022
EGFR Mutation-Positive Unresectable Stage III Non-Squamous Lung Cancer Is Associated with a High Incidence of Brain MetastasisHongsik Kim, Sehhoon Park, Hyun Ae Jung, et al.
Anticancer Research|February 11, 2014
Prognostic factor analysis in core-binding factor-positive acute myeloid leukemiaHyun Ae Jung, Chi Hoon Maeng, Silvia Park, et al.
Cancer Research and Treatment|July 27, 2019
Clinical Characteristics and Outcomes of Non-small Cell Lung Cancer Patients with HER2 Alterations in KoreaKangkook Lee, Hyun Ae Jung, Jong-Mu Sun, et al.
Translational Lung Cancer Research|March 15, 2021
Comprehensive evaluation of the clinical utility of plasma EGFR test in non-small cell lung cancer patients with acquired resistance to first-line EGFR inhibitorsHongsik Kim, Hyun Ae Jung, Se-Hoon Lee, et al.
Annals of Hematology|June 29, 2012
Prognostic relevance of pretreatment quality of life in diffuse large B-cell lymphoma patients treated with rituximab-CHOP: results from a prospective cohort studyHyun Ae Jung, Silvia Park, Jin Hyun Cho, et al.
Lung Cancer (Amsterdam, Netherlands)|March 17, 2024
Survival benefit in EGFR-wild and ALK negative NSCLC patients who participate in clinical trials compared to standard-of-care: Propensity-matched analysisHyun Ae Jung, Boram Park, Sehhoon Park, et al.
Pageof 15